Acute treatment of migraine in children and adolescents

Cristiano Termine, Matteo Ferri, Umberto Balottin

Research output: Contribution to journalArticle

Abstract

The management of headaches with juvenile onset presents several problems, related not only to appropriate drug selection but also to the specific features distinguishing headache disorders in children and adolescents: a child is not a "little adult". Many age-related factors influence the clinical expression of headache and these should be taken into account not only in the treatment, but also in the diagnosis, of juvenile headache. Few randomised placebo-controlled clinical trials of acute or preventive drugs have been conducted in paediatric headache patients, and those that have show a high placebo response rate in children (e.g. up to 55% for prophylactic drugs and up to 69% for symptomatic ones). The available data on symptomatic drugs are presented and discussed, focusing, in particular, on mechanisms of action, evidence of efficacy, and tolerability.

Original languageEnglish
Pages (from-to)63-69
Number of pages7
JournalFunctional Neurology
Volume23
Issue number2
Publication statusPublished - Apr 2008

Fingerprint

Migraine Disorders
Headache
Pharmaceutical Preparations
Placebos
Headache Disorders
Age Factors
Therapeutics
Randomized Controlled Trials
Pediatrics

Keywords

  • Acute treatment
  • Adolescence
  • Childhood
  • Migraine
  • Review

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Acute treatment of migraine in children and adolescents. / Termine, Cristiano; Ferri, Matteo; Balottin, Umberto.

In: Functional Neurology, Vol. 23, No. 2, 04.2008, p. 63-69.

Research output: Contribution to journalArticle

Termine, Cristiano ; Ferri, Matteo ; Balottin, Umberto. / Acute treatment of migraine in children and adolescents. In: Functional Neurology. 2008 ; Vol. 23, No. 2. pp. 63-69.
@article{1b13ba1791f94c58bb2482c6466f0c78,
title = "Acute treatment of migraine in children and adolescents",
abstract = "The management of headaches with juvenile onset presents several problems, related not only to appropriate drug selection but also to the specific features distinguishing headache disorders in children and adolescents: a child is not a {"}little adult{"}. Many age-related factors influence the clinical expression of headache and these should be taken into account not only in the treatment, but also in the diagnosis, of juvenile headache. Few randomised placebo-controlled clinical trials of acute or preventive drugs have been conducted in paediatric headache patients, and those that have show a high placebo response rate in children (e.g. up to 55{\%} for prophylactic drugs and up to 69{\%} for symptomatic ones). The available data on symptomatic drugs are presented and discussed, focusing, in particular, on mechanisms of action, evidence of efficacy, and tolerability.",
keywords = "Acute treatment, Adolescence, Childhood, Migraine, Review",
author = "Cristiano Termine and Matteo Ferri and Umberto Balottin",
year = "2008",
month = "4",
language = "English",
volume = "23",
pages = "63--69",
journal = "Functional Neurology",
issn = "0393-5264",
publisher = "CIC Edizioni Internazionali s.r.l.",
number = "2",

}

TY - JOUR

T1 - Acute treatment of migraine in children and adolescents

AU - Termine, Cristiano

AU - Ferri, Matteo

AU - Balottin, Umberto

PY - 2008/4

Y1 - 2008/4

N2 - The management of headaches with juvenile onset presents several problems, related not only to appropriate drug selection but also to the specific features distinguishing headache disorders in children and adolescents: a child is not a "little adult". Many age-related factors influence the clinical expression of headache and these should be taken into account not only in the treatment, but also in the diagnosis, of juvenile headache. Few randomised placebo-controlled clinical trials of acute or preventive drugs have been conducted in paediatric headache patients, and those that have show a high placebo response rate in children (e.g. up to 55% for prophylactic drugs and up to 69% for symptomatic ones). The available data on symptomatic drugs are presented and discussed, focusing, in particular, on mechanisms of action, evidence of efficacy, and tolerability.

AB - The management of headaches with juvenile onset presents several problems, related not only to appropriate drug selection but also to the specific features distinguishing headache disorders in children and adolescents: a child is not a "little adult". Many age-related factors influence the clinical expression of headache and these should be taken into account not only in the treatment, but also in the diagnosis, of juvenile headache. Few randomised placebo-controlled clinical trials of acute or preventive drugs have been conducted in paediatric headache patients, and those that have show a high placebo response rate in children (e.g. up to 55% for prophylactic drugs and up to 69% for symptomatic ones). The available data on symptomatic drugs are presented and discussed, focusing, in particular, on mechanisms of action, evidence of efficacy, and tolerability.

KW - Acute treatment

KW - Adolescence

KW - Childhood

KW - Migraine

KW - Review

UR - http://www.scopus.com/inward/record.url?scp=50849132947&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=50849132947&partnerID=8YFLogxK

M3 - Article

C2 - 18671905

AN - SCOPUS:50849132947

VL - 23

SP - 63

EP - 69

JO - Functional Neurology

JF - Functional Neurology

SN - 0393-5264

IS - 2

ER -